Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis (Q28756161)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: November 2007)

edit

Language	Label	Description	Also known as
English	Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis	scientific article (publication date: November 2007)

Statements

instance of

scholarly article

0 references

title

Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis (English)

0 references

main subject

cell biology

0 references

idiopathy

0 references

polycythemia vera

1 reference

based on heuristic

inferred from title

myelofibrosis

1 reference

based on heuristic

inferred from title

author name string

Donna M Williams

series ordinal

1

0 references

Ann H Kim

series ordinal

2

0 references

Ophelia Rogers

series ordinal

3

0 references

Jerry L Spivak

series ordinal

4

0 references

Alison R Moliterno

series ordinal

5

0 references

language of work or name

English

0 references

publication date

November 2007

0 references

published in

Experimental Hematology

0 references

volume

35

0 references

issue

11

0 references

page(s)

1641-6

0 references

cites work

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

16 March 2017

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

16 March 2017

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

16 March 2017

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

16 March 2017

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

7 April 2017

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

7 April 2017

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

7 April 2017

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Letter: Bone-marrow responses in polycythemia vera

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Polycythemia vera: stem-cell and probable clonal origin of the disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

3 June 2018

Anaemia characterises patients with myelofibrosis harbouring Mpl mutation.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

27 November 2018

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

27 November 2018

The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

27 November 2018

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

27 November 2018

Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149910

retrieved

27 November 2018

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17920755

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17920755

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17920755

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17920755

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17920755

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.EXPHEM.2007.08.010

0 references

PMC publication ID

2149910

0 references

PubMed publication ID

17920755

0 references

ResearchGate publication ID

5923804

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28756161&oldid=1535736182"